Vanguard Group’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $6.81M | Buy |
4,226,941
+2,707
| +0.1% | +$4.26K | ﹤0.01% | 3139 |
|
|
2025
Q3 | $7.1M | Buy |
4,224,234
+11,120
| +0.3% | +$18K | ﹤0.01% | 3154 |
|
|
2025
Q2 | $5.1M | Sell |
4,213,114
-212,878
| -5% | -$309K | ﹤0.01% | 3210 |
|
|
2025
Q1 | $5.62M | Buy |
4,425,992
+109,311
| +3% | +$286K | ﹤0.01% | 3120 |
|
|
2024
Q4 | $14M | Sell |
4,316,681
-40,859
| -0.9% | -$147K | ﹤0.01% | 2771 |
|
|
2024
Q3 | $14.3M | Buy |
4,357,540
+222,221
| +5% | +$866K | ﹤0.01% | 2777 |
|
|
2024
Q2 | $17.6M | Buy |
4,135,319
+457,641
| +12% | +$4.46M | ﹤0.01% | 2635 |
|
|
2024
Q1 | $54.1M | Sell |
3,677,678
-631,716
| -15% | -$9.55M | ﹤0.01% | 2135 |
|
|
2023
Q4 | $41.5M | Sell |
4,309,394
-105,530
| -2% | -$730K | ﹤0.01% | 2262 |
|
|
2023
Q3 | $20.6M | Buy |
4,414,924
+36,396
| +0.8% | +$181K | ﹤0.01% | 2541 |
|
|
2023
Q2 | $23.4M | Sell |
4,378,528
-89,871
| -2% | -$554K | ﹤0.01% | 2527 |
|
|
2023
Q1 | $32M | Buy |
4,468,399
+24,035
| +0.5% | +$145K | ﹤0.01% | 2386 |
|
|
2022
Q4 | $29.8M | Buy |
4,444,364
+262,123
| +6% | +$1.44M | ﹤0.01% | 2432 |
|
|
2022
Q3 | $14.5M | Buy |
4,182,241
+251,279
| +6% | +$961K | ﹤0.01% | 2771 |
|
|
2022
Q2 | $11.6M | Sell |
3,930,962
-101,277
| -3% | -$532K | ﹤0.01% | 2915 |
|
|
2022
Q1 | $35.5M | Buy |
4,032,239
+86,061
| +2% | +$950K | ﹤0.01% | 2474 |
|
|
2021
Q4 | $63.3M | Buy |
3,946,178
+50,038
| +1% | +$942K | ﹤0.01% | 2220 |
|
|
2021
Q3 | $81.6M | Sell |
3,896,140
-44,924
| -1% | -$1.08M | ﹤0.01% | 2095 |
|
|
2021
Q2 | $106M | Buy |
3,941,064
+106,790
| +3% | +$3.13M | ﹤0.01% | 1971 |
|
|
2021
Q1 | $122M | Buy |
3,834,274
+258,690
| +7% | +$6.28M | ﹤0.01% | 1844 |
|
|
2020
Q4 | $81.7M | Buy |
3,575,584
+274,797
| +8% | +$6.33M | ﹤0.01% | 1937 |
|
|
2020
Q3 | $83.1M | Buy |
3,300,787
+18,903
| +0.6% | +$516K | ﹤0.01% | 1785 |
|
|
2020
Q2 | $91.6M | Buy |
3,281,884
+32,556
| +1% | +$566K | ﹤0.01% | 1727 |
|
|
2020
Q1 | $18.9M | Buy |
3,249,328
+39,798
| +1% | +$361K | ﹤0.01% | 2311 |
|
|
2019
Q4 | $34.9M | Sell |
3,209,530
-3,317
| -0.1% | -$32.8K | ﹤0.01% | 2274 |
|
|
2019
Q3 | $41M | Buy |
3,212,847
+14,633
| +0.5% | +$211K | ﹤0.01% | 2166 |
|
|
2019
Q2 | $54.3M | Buy |
3,198,214
+161,920
| +5% | +$2.78M | ﹤0.01% | 2061 |
|
|
2019
Q1 | $54.6M | Buy |
3,036,294
+485,167
| +19% | +$8.39M | ﹤0.01% | 2043 |
|
|
2018
Q4 | $32.4M | Buy |
2,551,127
+280,586
| +12% | +$4.71M | ﹤0.01% | 2235 |
|
|
2018
Q3 | $48.7M | Buy |
2,270,541
+165,937
| +8% | +$3.54M | ﹤0.01% | 2156 |
|
|
2018
Q2 | $43.5M | Buy |
2,104,604
+415,381
| +25% | +$9.36M | ﹤0.01% | 2193 |
|
|
2018
Q1 | $42.5M | Buy |
1,689,223
+124,567
| +8% | +$3.03M | ﹤0.01% | 2156 |
|
|
2017
Q4 | $29.7M | Buy |
1,564,656
+44,249
| +3% | +$826K | ﹤0.01% | 2323 |
|
|
2017
Q3 | $28.1M | Buy |
1,520,407
+129,085
| +9% | +$2.24M | ﹤0.01% | 2329 |
|
|
2017
Q2 | $24.4M | Buy |
1,391,322
+38,458
| +3% | +$734K | ﹤0.01% | 2372 |
|
|
2017
Q1 | $25.2M | Buy |
1,352,864
+44,680
| +3% | +$862K | ﹤0.01% | 2346 |
|
|
2016
Q4 | $26.7M | Buy |
1,308,184
+10,025
| +0.8% | +$252K | ﹤0.01% | 2278 |
|
|
2016
Q3 | $38.8M | Buy |
1,298,159
+5,957
| +0.5% | +$177K | ﹤0.01% | 2048 |
|
|
2016
Q2 | $34.9M | Buy |
1,292,202
+149,611
| +13% | +$3.37M | ﹤0.01% | 2060 |
|
|
2016
Q1 | $21.4M | Buy |
1,142,591
+41,537
| +4% | +$791K | ﹤0.01% | 2278 |
|
|
2015
Q4 | $34.1M | Buy |
1,101,054
+25,017
| +2% | +$760K | ﹤0.01% | 2064 |
|
|
2015
Q3 | $23M | Buy |
1,076,037
+273,498
| +34% | +$8.58M | ﹤0.01% | 2225 |
|
|
2015
Q2 | $30.5M | Buy |
802,539
+83,091
| +12% | +$2.73M | ﹤0.01% | 2172 |
|
|
2015
Q1 | $22.6M | Buy |
719,448
+148,918
| +26% | +$5.05M | ﹤0.01% | 2275 |
|
|
2014
Q4 | $20M | Buy |
570,530
+3,903
| +0.7% | +$97.3K | ﹤0.01% | 2238 |
|
|
2014
Q3 | $11.8M | Buy |
566,627
+177,983
| +46% | +$3.68M | ﹤0.01% | 2419 |
|
|
2014
Q2 | $8.45M | Buy |
388,644
+146,560
| +61% | +$3.08M | ﹤0.01% | 2579 |
|
|
2014
Q1 | $6.74M | Buy |
242,084
+118,588
| +96% | +$4.19M | ﹤0.01% | 2678 |
|
|
2013
Q4 | $3.39M | Buy |
+123,496
| New | +$3.23M | ﹤0.01% | 2973 |
|
Other funds holding MGNX
AC
JFG
WA
Vanguard Group's MGNX Position: Q4 2025 in Review
Vanguard Group increased its MacroGenics (MGNX) stake by 0.06% in Q4 2025, buying an estimated $4.26K and bringing the position to 4,226,941 shares worth $6.81M. The position accounts for ﹤0.01% of the portfolio, ranked #3139.
Vanguard Group first reported a position in MGNX in Q4 2013 and has held it in 49 quarters since. The position peaked at $122M in Q1 2021. 88 funds tracked by Wall St. Rank hold MGNX as of Q4 2025.
- Vanguard Group held 4,226,941 shares of MacroGenics worth $6.81M as of Q4 2025.
- Vanguard Group bought 2,707 MacroGenics shares in Q4 2025, an estimated $4.26K.
- MacroGenics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3139 holding.
- Vanguard Group first reported a position in MacroGenics in Q4 2013 and has held it in 49 quarters since.
- Vanguard Group's MacroGenics position peaked at $122M in Q1 2021.
- 88 funds tracked by Wall St. Rank held MacroGenics as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.